Mar. 2026
Qurgen has expanded the clinical trial of its cell-conversion cancer therapy in the following four additional clinical sites:
- Sarah Cannon Research Institute Tennessee;
- HCA HealthONE Denver;
- California Research Institute;
- Comprehensive Cancer Centers of Nevada.